Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Hisse Senetlerindeki Sıralama #16725
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Hisse Fiyatı
$3.78
Son senkronizasyon: 2026-03-17
Piyasa Değeri
$276.54M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
45.53%
Ülke
CA
Ticaret NervGen Pharma Corp. (NGEN)

Kategori

NervGen Pharma Corp. (NGEN) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $3.98 - 2026-03-01

Gün sonu en düşük fiyat: $1.12 - 2019-03-01
NervGen Pharma Corp. için hisse fiyatı geçmişi: 2019 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.21 -10.03%
AU
$755.10 7.83%
CH